Evidence map›Paper›PMID 33114620›Full record

ArticleMolecules (Basel, Switzerland)2020

Type 2 Diabetes Alters Vascular Cannabinoid Receptor 1 Expression, Phosphorylation Status, and Vasorelaxation in Rat Aorta.

Enrique Sánchez-Pastor, Xóchitl Trujillo, Christian Ramos-Flores, Mónica Ríos-Silva, Felipa Andrade, Yolitzy Cárdenas, Elena Castro, Zorayda Urzúa, Oscar Newton-Sánchez, Miguel Huerta

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Enrique Sánchez-PastorEnrico Stefani Research Unit, University Center for Biomedical Research, University of Colima, Colima CP 28045, Mexico.ORCID 0000-0003-2337-3355
Xóchitl TrujilloEnrico Stefani Research Unit, University Center for Biomedical Research, University of Colima, Colima CP 28045, Mexico.ORCID 0000-0001-7506-1674
Christian Ramos-FloresEnrico Stefani Research Unit, University Center for Biomedical Research, University of Colima, Colima CP 28045, Mexico.
Mónica Ríos-SilvaEnrico Stefani Research Unit, University Center for Biomedical Research, University of Colima, Colima CP 28045, Mexico.
Felipa AndradeNational Technological Institute of Mexico/Technological Institute of Colima, Avenida Tecnológico No. 1, Villa de Álvarez, Colima CP 28976, Mexico.
Yolitzy CárdenasEnrico Stefani Research Unit, University Center for Biomedical Research, University of Colima, Colima CP 28045, Mexico.
Elena CastroEnrico Stefani Research Unit, University Center for Biomedical Research, University of Colima, Colima CP 28045, Mexico.
Zorayda UrzúaMexican Institute of Social Security, Family Medicine Unit #17, Manzanillo, Colima CP 28219, Mexico.
Oscar Newton-SánchezFaculty of Medicine, University of Colima, Colima CP 28040, Mexico.ORCID 0000-0002-1496-1158
Miguel HuertaEnrico Stefani Research Unit, University Center for Biomedical Research, University of Colima, Colima CP 28045, Mexico.ORCID 0000-0001-8515-0777
Universidad de Colima · MXMexican Social Security Institute · MXTecnológico Nacional de México · MX

Funding

Consejo Nacional de Ciencia y Tecnología 152773
6 · The paper itself

Abstract

Previous studies have suggested a role of the endocannabinoid system in metabolic diseases, such as diabetes. We investigated the effect of diabetes on cannabinoid receptor type 1 (CB

Indexed as

Gene Expression RegulationVasodilationAnimalsAortaBlood GlucoseBody WeightDiabetes Mellitus, Type 2MalePhosphorylationProtein TransportRatsRats, WistarReceptor, Cannabinoid, CB1Blood GlucoseReceptor, Cannabinoid, CB1cannabinoidCB1 receptor expressionCNR1diabetesvasorelaxation

Identifiers

PMID33114620
PMCPMC7662259
OpenAlexW3097783661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.